Axon Enterprise, Inc. (NASDAQ:AXON) Insider Jeffrey C. Kunins Sells 1,035 Shares

Axon Enterprise, Inc. (NASDAQ:AXON) insider Jeffrey C. Kunins sold 1,035 shares of the stock in a transaction on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total value of $646,326.45. Following the sale, the insider now owns 124,243 shares in the company, valued at approximately $77,586,026.21. This represents a 0.83 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $610.98 on Friday. The company’s fifty day moving average is $578.35 and its 200 day moving average is $428.57. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 52 week low of $241.72 and a 52 week high of $698.67. The stock has a market cap of $46.59 billion, a PE ratio of 157.88, a PEG ratio of 14.19 and a beta of 1.01.

Analyst Upgrades and Downgrades

AXON has been the topic of a number of recent research reports. Needham & Company LLC increased their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Northland Securities increased their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Robert W. Baird upped their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Finally, JMP Securities raised their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $488.67.

Institutional Investors Weigh In On Axon Enterprise

Hedge funds and other institutional investors have recently modified their holdings of the stock. Quent Capital LLC grew its position in Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after acquiring an additional 75 shares during the last quarter. Prestige Wealth Management Group LLC grew its holdings in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares during the last quarter. Brooklyn Investment Group bought a new position in shares of Axon Enterprise in the third quarter worth approximately $41,000. Planning Capital Management Corp increased its stake in shares of Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after buying an additional 55 shares during the period. Finally, Friedenthal Financial bought a new stake in Axon Enterprise during the 3rd quarter valued at $51,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.